Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/1998
04/01/1998EP0831876A1 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
04/01/1998EP0831873A1 The treatment of hiv and other viral infections using combinatory therapy
04/01/1998EP0831863A1 Method of improving animal health
04/01/1998EP0831854A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
04/01/1998EP0831852A1 Nucleosides with anti-hepatitis b virus activity
04/01/1998EP0831846A1 Capped synthetic rna, analogs, and aptamers
04/01/1998EP0831832A1 Methods of combatting infectious diseases using dicationic bis-benzimidazoles
04/01/1998EP0831831A1 Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
04/01/1998EP0831830A1 Imidazole compounds
04/01/1998EP0831828A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin
04/01/1998EP0831826A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
04/01/1998EP0831815A1 Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
04/01/1998EP0831813A1 Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor
04/01/1998EP0831811A1 Methods of treating microbial infections
04/01/1998EP0831794A1 Acyclovir derivatives for topical use
04/01/1998EP0831783A1 Oral veterinary fluoroquinolone antibacterial composition for extended duration of therapy and method of treating
04/01/1998EP0799047A4 Viscous liquid conditioning topical germicides
04/01/1998CN1177982A System for the expression of heterologous antigens as fusion proteins
04/01/1998CN1177927A Extracts of shark cartilage, process of production and uses thereof
04/01/1998CN1177909A Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
04/01/1998CN1177597A Polyene antibiotics 3874 H1-H6, preparation method and use thereof
04/01/1998CN1177481A Medicinal composition for treating tinea manus and pedis
04/01/1998CN1177479A Application of scutellaria baicalensis glucoside as germicide for skin and mucosa
04/01/1998CN1177478A Bath lotion containing total alkaloid of sophora alopecuroide
04/01/1998CA2216486A1 Substituted diamino-1,3,5-triazine derivatives
03/1998
03/31/1998US5734081 Arylthio compounds
03/31/1998US5734057 HIV protease inhibitors and intermediates
03/31/1998US5733921 Isothiazolone compounds
03/31/1998US5733907 Aids therapy
03/31/1998US5733899 Method for treating infection using steroid based pharmaceutical compositions
03/31/1998US5733896 Viricide for retrovirus
03/31/1998US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
03/31/1998US5733781 Dna and human immunodefficiency virus inhibitors
03/31/1998US5733742 Polyclonal immunoglobulin fab fragments
03/31/1998US5733556 Newcastle disease virus combination vaccine
03/31/1998US5733555 Live bovine syncytial virus
03/31/1998US5733554 Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease
03/31/1998US5733548 Stimulating t-cell response
03/31/1998US5733540 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
03/30/1998CA2216763A1 N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug
03/30/1998CA2214441A1 Polymer/hydrogen peroxide complexes
03/26/1998WO1998012332A1 Compositions and methods for treating intracellular diseases
03/26/1998WO1998012331A1 Novel polypeptide originating in hemophilus paragallinarum and process for producing the same
03/26/1998WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998WO1998012200A1 A crystalline substance of cefditoren pivoxyl and the production of the same
03/26/1998WO1998012191A1 Industrial process for producing quinolone-carboxylic acid derivatives and intermediates for synthesis of the same
03/26/1998WO1998012176A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/26/1998WO1998011923A1 Identification of agents that protect against inflammatory injury to neurons
03/26/1998WO1998011916A1 Viral defective interfering particles and uses thereof
03/26/1998WO1998011915A1 Strain selection of pneumococcal surface proteins
03/26/1998WO1998011907A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
03/26/1998WO1998011887A2 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
03/26/1998WO1998011874A1 Pharmaceutical composition forming a gel
03/26/1998WO1998011866A1 Mouthwash comprising calcium and phosphate ions in supersaturated solution
03/26/1998WO1998011779A1 Delivery of therapeutic gene products by intestinal cell expression
03/26/1998WO1998011778A1 Antimicrobial treatment for herpes simplex virus and other infectious diseases
03/26/1998WO1998007874A3 New systems for regulating genetic expression
03/26/1998WO1997040063A3 Pathogenic escherichia coli associated protein espa
03/26/1998DE19704301C1 Human endoglin gene promoter
03/26/1998DE19639103A1 DNA construct with inhibitory mutation and corrective mutation
03/26/1998CA2267343A1 Strain selection of pneumococcal surface proteins
03/26/1998CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998CA2266656A1 Compositions and methods for treating intracellular diseases
03/26/1998CA2266639A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/26/1998CA2265896A1 Identification of agents that protect against inflammatory injury to neurons
03/26/1998CA2265571A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
03/26/1998CA2264744A1 Delivery of therapeutic gene products by intestinal cell expression
03/26/1998CA2236165A1 Novel polypeptide from haemophilus paragallinarum and process for preparing the same
03/25/1998EP0830861A1 Use of PKC inhibitors for the manufacture of a medicament for the treatment of HTLV-1 infections
03/25/1998EP0830860A1 Use of PKC inhibitors for the manufacture of a medicament for the treatment of AIDS
03/25/1998EP0830602A1 Expression system for non-secretor genes
03/25/1998EP0830456A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE
03/25/1998EP0830380A1 Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof
03/25/1998EP0830372A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
03/25/1998EP0830147A1 Polymyxin conjugates
03/25/1998EP0830142A1 Viral agent associated with mystery swine disease
03/25/1998EP0830141A1 Improved virus vaccines
03/25/1998EP0830135A1 Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders
03/25/1998EP0830130A1 Tnf-alpha converting enzyme
03/25/1998EP0714306B1 Inactivated respiratory syncytial viral vaccines
03/25/1998CN1177378A Stabilized external guide sequences
03/25/1998CN1177357A Bismuth compound
03/25/1998CN1177351A Hydroxylamine derivatives useful for enhancing molecular chaperon prodn. and the prepn. thereof
03/25/1998CN1177303A Application of lysozyme dimer
03/25/1998CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine
03/24/1998USRE35754 Cephem derivatives
03/24/1998US5731328 Administering 2-phenyl-3-aroylbenzothiophene compounds to a patient
03/24/1998US5731319 Antiallergens; antihistamines
03/24/1998US5731289 Bridged dipeptide compounds which have a stimulating activity on cell division, especially in myelopoietic and bone marrow cells
03/24/1998US5731286 Cyclic neurokinin A antagonists
03/24/1998US5731196 Salmonella virulence genes
03/24/1998US5731187 Process for preparing hepatitis A (HAV) antigens and vaccines
03/24/1998US5731168 Method for making heteromultimeric polypeptides
03/24/1998US5731151 Tuberculosis vaccine
03/24/1998US5731008 Electrically hydrolyzed salines as microbicides
03/24/1998US5731006 Gastrointestinal mucosa-adherent granules, pharmaceutical preparations and a coating composition
03/24/1998US5730998 Administering substance p antagonist
03/24/1998US5730980 Methods and compositions for ameliorating the symptoms of sepsis
03/24/1998US5730971 Mixture of flavin adenine dinucleotide and porcien liver extract
03/24/1998CA2211008A1 Nucleic acid constructs containing hybrid promoters for use in gene therapy
1 ... 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 ... 1798